Ravindra N. Singh

Singh is most known for researching RNA biology and molecular genetics; particularly for the invention of the Intron Splicing Silencer N1 (ISS-N1) target that led to the first FDA-approved drug (Spinraza/Nusinersen) for the treatment of spinal muscular atrophy (SMA). He is the recipient of several awards, including the Salsbury Endowment at Iowa State University and the 2006 Presidential Early Career Award for Scientists and Engineers (PECASE). Provided by Wikipedia
-
1
-
2
-
3
-
4
-
5by Cameron A. Petrie, Hector A. Orengo, Adam S. Green, Joanna R. Walker, Arnau Garcia, Francesc Conesa, J. Robert Knox, Ravindra N. SinghGet full text
Published 2018-12-01
Article -
6
-
7by Adam S. Green, Hector A. Orengo, Aftab Alam, Arnau Garcia-Molsosa, Lillian M. Green, Francesc Conesa, Amit Ranjan, Ravindra N. Singh, Cameron A. PetrieGet full text
Published 2019-09-01
Article -
8by Xinyi Liu, Diane L Lister, Zhijun Zhao, Cameron A Petrie, Xiongsheng Zeng, Penelope J Jones, Richard A Staff, Anil K Pokharia, Jennifer Bates, Ravindra N Singh, Steven A Weber, Giedre Motuzaite Matuzeviciute, Guanghui Dong, Haiming Li, Hongliang Lü, Hongen Jiang, Jianxin Wang, Jian Ma, Duo Tian, Guiyun Jin, Liping Zhou, Xiaohong Wu, Martin K JonesGet full text
Published 2018-01-01
Article -
9by Xinyi Liu, Diane L Lister, Zhijun Zhao, Cameron A Petrie, Xiongsheng Zeng, Penelope J Jones, Richard A Staff, Anil K Pokharia, Jennifer Bates, Ravindra N Singh, Steven A Weber, Giedre Motuzaite Matuzeviciute, Guanghui Dong, Haiming Li, Hongliang Lü, Hongen Jiang, Jianxin Wang, Jian Ma, Duo Tian, Guiyun Jin, Liping Zhou, Xiaohong Wu, Martin K JonesGet full text
Published 2017-01-01
Article